Do galectins play a role in venous thrombosis? a review
Authors:
- Jose A. DiazJDJose A. Diaz
- Eduardo RamacciottiEREduardo Ramacciotti
- Thomas W. WakefieldTWThomas W. Wakefield
- 1 May 2010
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 125 (5) , 373-376
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agentsCancer Science, 2009
- On the Trail of MicroparticlesCirculation Research, 2009
- Regulation of Prostate Cancer Progression by Galectin-3The American Journal of Pathology, 2009
- Galectin-1 Is a Novel Functional Receptor for Tissue Plasminogen Activator in Pancreatic CancerGastroenterology, 2009
- Galectin-3 Mediates Nuclear β-Catenin Accumulation and Wnt Signaling in Human Colon Cancer Cells by Regulation of Glycogen Synthase Kinase-3β ActivityCancer Research, 2009
- Microparticle Surface Proteins Are Associated With Experimental Venous Thrombosis: A Preliminary StudyClinical and Applied Thrombosis/Hemostasis, 2008
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal FibrosisThe American Journal of Pathology, 2008
- Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cellsBlood, 2006
- Decreased venous thrombosis with an oral inhibitor of P selectinJournal of Vascular Surgery, 2005
- Effect of P-Selectin on Phosphatidylserine Exposure and Surface-Dependent Thrombin Generation on MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2005